Formosa Pharmaceuticals, Inc. (6838.TW) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
Formosa Pharmaceuticals, Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 143.36 m TWD | 9.50 m TWD |
| Gross profit | 118.99 m TWD | -1.60 m TWD |
| Operating income | -167.81 m TWD | -170.61 m TWD |
| EBIT | -179.01 m TWD | -83.52 m TWD |
| Net income | -201.01 m TWD | -83.57 m TWD |
| Diluted EPS – continuing operations | -1.33 TWD | -0.55 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002 to treat infectious eye diseases, such as conjunctivitis, keratitis, blepharitis, and meibomian gland dysfunction; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer. It has a strategic partnership with Eyenovia, Inc. for the development of novel ophthalmic therapeutic; and Singapore Eye Research Institute to develop ophthalmic formulations for corneal diseases. Formosa Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Taipei City, Taiwan.
More stocks
- Korea Petroleum Industries Co (004090.KS)
- Easywell Biomedicals Inc. (1799.TWO)
- United Purification Technology Co., Ltd. (6977.TWO)
- Wam Active Ltd (WAA.AX)
- LiveWire Group, Inc. (LVWR)
- Taiwan IC Packaging (3372.TWO)
- Patagonia Gold Corp (PGDC.V)
- Tung Thih Electronic Co Ltd (3552.TWO)
- Cubtek Inc. (2252.TWO)
- Atlantic Sapphire As (ASA.OL)
- Taiwan Environment Scientific Co., Ltd. (8476.TW)
- Liying EPTech (7820.TWO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.